The possibility that endogenous epinephrine, norepinephrine or angiotensin is involved in the response of the peripheral circulation to kinekard, a plasma pressor fraction of relatively low molecular weight, was investigated in anesthetized dogs on heart-lung bypass and isolated perfused gracilis muscle preparations. The prior administration of bretylium tosylate, guanethidine or the /3-adrenergic antagonist, propranolol, failed to modify the pressor action of kinekard. This pressor action was blocked by the prior addition of the a-adrenergic antagonist, phenoxybenzamine. These results have been interpreted to mean that kinekard acts on the a-receptor sites in the peripheral circulation to cause constriction and that this response does not involve or depend on the release of stored catecholamines.
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• The isolation from human and other blood plasma of kinekard, a pressor fraction with a relatively low molecular weight, 1 -4 has been described. Kinekard has a positive inotropic effect on isolated mammalian and amphibian hearts and a peripheral constrictor activity in dogs on heart-lung bypass and dog isolated hind-limb preparations. B Although it has been shown that kinekard is not epinephrine, norepinephrine or angiotensin, the similarity between these properties of kinekard and those described in the literature for epinephrine, norepinephrine and angiotensin, 6 -7 requires consideration of the possibility that one of these takes part in the From the Baker Medical Research Institute, Commercial Road, Prahran S.I, Victoria, Australia.
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Accepted for publication April 11, 1966. 528 action of kinekard. The paper describes a series of experiments planned to this end.
Methods Dogs on heart-lung bypass 5 and dog isolated gracilis muscle preparations 8 were used to investigate the effect of kinekard on the peripheral circulation before and after administration of adrenergic antagonists. ANESTHESIA Dogs were given 30 mg of morphine sulfate im approximately 1 hour before anesthesia was induced with sodium thiopentone (20 to 30 mg/kg iv). A surgical level of anesthesia was maintained with nitrous oxide-oxygen mixture (2:1) delivered from an intermittent positive pressure respirator at a rate of 2 liters/min, with supplementary doses of thiopentone given from time to time as required.
DOG HEART-LUNG BYPASS PREPARATION
The method used has been fully described previously. 5 Anesthetized healthy mongrel dogs (12-15 kg) were heparinized (2 mg/kg per hour iv) and placed on heart-lung bypass using a Kay Cross disc oxygenator, the vascular system being perfused by a nonpulsatile (Mono) pump, through the right common carotid artery, at a Cimdiion Risurcb, Vol. XIX, Sepfmhtr 1966 KINEKARD AND ADRENERGIC ANTAGONISTS 529 constant flow rate which varied between 100 and 120 ml/ kg per min in different experiments. Appropriate cannulation allowed the independent measurement of venous outflows from the splanchnic, renal, lower inferior vena cava (IVC), superior vena cava (SVC) and azygos vascular fields and coronary sinus outflow.
Blood flow through a particular organ or vascular field was measured as previously described 5 by determining the time required for 100 ml of blood to collect in a graduated cylinder placed in circuit between the relevant venous return eannula and the heart-lung machine. During collection of the 100-ml blood sample the connection leading from the cylinder to the reservoir attached to the oxygenator was clamped; after 100 ml of blood had collected in the cylinder the clamp was released and the collected blood allowed to drain by gravity into the venous reservoir. Preliminary experiment showed that pressure in the cannulated venous segments did not change during the collection procedure; changes in flow due to the opposing pressure head developed during the collection of blood in the collecting cylinders therefore were considered negligible for the purposes of these experiments.
In four experiments, cardiac rate was controlled by electrical stimulation through two wires attached to die anterior surface of the right ventricle. The stimuli were pulses of 1 msec duration delivered from a Tektronix wave form and pulse generator (type 160,161) at approximately twice the threshold voltage and a frequency of 180/min. In another six experiments the ventricle was made to fibrillate by the application of 10 volts d-c between two points on the anterior surface of the heart.
In all experiments the mean systemic (ar-terial) pressure was indicated by a mercury manometer connected to a cannula inserted into either the left internal mammary or right femoral artery.
ISOLATED GRACILIS MUSCLE PREPARATION
This preparation, based on that described by Renkin and Rosell, 8 consists of an isolated gracilis muscle perfused under conditions of constant flow so that changes in the resistance to blood flow through the muscle are reflected as changes in perfusion pressure. The perfusion system is shown schematically in Figure 1 . Perfusion was effected by means of a Dual Infusion/Withdrawal Pump (Model 600-910, Harvard Apparatus Co., Inc.) at a flow rate which produced a constant perfusion pressure in the range of 80 to 120 mm Hg. Usually this meant a flow rate of 1.9 ml/min. Systemic arterial pressure and perfusion pressures were detected with Statham strain gauges (type P23 D [b]), the output of the strain gauge amplifiers being displayed on an ultraviolet light photographic recorder (Consolidated Electrodynamics Corporation, type 5124). Systemic arterial pressure was measured in the femoral artery on the side opposite to the muscle preparation.
The effectiveness with which the gracilis muscle had been isolated from the systemic circulation was proved by injecting 0.5 mg of norepinephrine into the systemic circulation. If the gracilis perfusion pressure remained unchanged despite a marked change in systemic pressure, the isolation was considered to be complete. Test drugs were administered through the perfusion line, care being taken to prevent the entry of air bubbles. Adrenergic antagonists were administered to the animal, including the isolated muscle, via the femoral vein. 
Effect of Kinekard, Epinephrine, Norepinephrine and Angiotensin on Perfusion Pressure and Blood Flow through the Various Vascular Fields of Dogs on Heart-Lung Bypass
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Renal flow fore another pressor drug was added. Perfusion pressure and regional blood flow were redetermined immediately before each pressor drug was added. Blood flow in any particular vascular field varied from preparation to preparation but in the absence of vasoactive drugs, remained constant for each particular preparation throughout the duration of these experiments. This individual variation in blood flow accounts for the apparently wide scatter of results presented in Table 1 .
Relatively high concentrations of epinephrine and norepinephrine were used to ensure that the subsequently induced a-adrenergic blockade was effective over a wide dose range* and to allow for the additional 3 liters of blood contained in the heart-lung bypass circulation.
The addition of kinekard to four preparations in which the heart rate was controlled and to six preparations in which fibrillation had been established resulted in an increased coronary flow similar to that already described for those preparations in which the heart rate was not regulated.
! _£ Effect of a-Adrenerglc Blockade on Kinekard Activity
Phenoxybenzamine (15 mg/kg iv) was used to produce a-adrenergic blockade which was regarded as being effective if 0.3 to 0.5 mg of epinephrine or norepinephrine, when added to the circulation, failed to increase either the systemic perfusion pressure or coronary blood flow. The effect of phenoxybenzamine on regional blood flow in these preparations is summarized in Table 3 , which shows the results of four typical preparations.
Two of these preparations were perfused under conditions of constant flow, so that changes in regional blood flow reflect the combined effect of a fall in perfusion pressure and vasodilation. In the other two experiments, perfusion pressure was maintained at the control level by adjusting the output of the perfusion pump, so that changes in T h e doses of epinephrine, norepinephrine and angiotensin used during these experiments were selected in an attempt to provide changes in the regional distribution of blood about equivalent in magnitude with that caused by 0.5-0.8 /*g of kinekard. Effect of kinekard, angiotenisn and epinephrine on systemic perfusion pressure and coronary blood flow before and after a-adrenergic blockade by phenoxybenzamine (15 mg/kg) in dog on heart-lung bypass (preparation 6). 0.8 ng kinekard, 0.5 mg epinephrine and 45 ng angiotensin injected (arrows) into a 15-kg dog.
regional blood flow recorded following the administration of phenoxybenzamine reflect the changed vascular resistance to blood flow. Under these conditions it is evident that a-adrenergic blockade increased blood flow and therefore caused vasodilation in all the vascular fields studied during these experiments.
In seven such experiments in which aadrenergic blockade had been established, kinekard was administered; in all, the effect of kinekard on the measured parameters of Table 4 , and some results from another typical experiment are displayed in Figure 2 . This figure shows the effect of kinekard, angiotensin and epinephrine on systemic perfusion pressure and coronary blood flow before and after the establishment of aadrenergic blockade by phenoxybenzamine.
It can be seen that although the blockade abolishes or reverses the effect of both epinephrine and Idnekard on coronary blood flow and systemic perfusion pressure, the effect of angiotensin was only partly blocked. The effect of angiotensin on systemic perfusion pressure and coronary blood flow in four other preparations, before and after a-adrenergic blockade, is summarized in Table 5 .
Effect of P-Adrenorglc Blockad* on Kinafcard Activity
In five experiments the /3-adrenergic antagonists, pronethalol or propranolol, were administered in doses (30 mg/kg) sufficient to abolish the depressor effect of 5 to 10 /ig/kg of isoproterenol on the systemic perfusion pressure. This failed to abolish either the rise in perfusion pressure or increase in coronary flow produced by Idnekard, epinephrine or angiotensin. The results of a typical experiment are displayed in Figure 3 .
Effect of BratyHum Tosylat* and GuoneHildin* on Klnekord Activity
In four experiments the effect of prior administration of bretylium tosylate (10 mg/kg), and in two other experiments the effect of the similar use of guanethidine (15 mg/kg), on the activity of Idnekard was determined. In each of these experiments the failure of 45 mg of ephedrine to produce a pressor response from guanethidine or bretylium tosylate-treated heart-lung bypass preparations was used as a criterion of the effective action of both bretylium and guanethidine. Both of these drugs, which deplete sympathomimetic nerve endings of catecholamines, failed to abolish or depress the effect of kinekard on the peripheral circulation of dogs as used in these experiments. The results of a typical experiment are displayed in Figure 4 . Effect of kinekard, angiotensin, and epinephrine on systemic perfusion pressure and coronary blood flow before and after the establishment of p-adrenergic blockade by propranolol (30 mg/kg) in a dog heart4ung bypass preparation (preparation 9). 0.8 tig kinekard, 0.45 mg epinephrine and 40 ^g angiotensin given at arrows as indicated to a 14-kg dog.
ISOLATED GRACILIS MUSCLE PREPARATION Effect of Kln.kord
In the six experiments in which (1 to 9 X 10" 3 ) fig of kinekard was injected into the perfusion system of the isolated gracilis muscle, a rise in perfusion pressure occurred. A typical response is shown in Figure 5 . The increase in perfusion pressure was dose de-pendent and ranged from 50 to 330 mm Hg.
Following the administration of phenoxybenzamine in doses sufficient to block the effect of 0. used to establish a-adrenand partially blocked in a third. These results are summarized in Table 6 and Figure 5 .
Discussion
These results indicate that administration of kinekard, epinephrine, norepinephrine or angiotensin to dogs on heart-lung bypass, perfused under conditions of constant flow and with the carotid and aortic baroreceptors left intact, is followed by an immediate rise in systemic perfusion pressure and a redistri-Circulattim Ratrcb, Vol. XIX, Stpumbtr 1966 bution of blood through the vascular fields.
Kinekard consistently caused a marked increase in coronary blood flow and decreased renal, inferior vena cava and azygos flows. These results are similar to those recorded after administration of epinephrine, norepinephrine and, to a lesser extent, angiotensin. This last drug caused an initial transient decrease in coronary flow, a finding in accord with the results described by others. 7 ' 10 Because the relationship between pressure and flow in an isolated vascular field is nonlinear 0 ' u and the perfusion pressure in the various fields changed following administration of the various pressor drugs, only trends in the change of resistance to blood flow through the various vascular fields can be assessed. The results indicate that following the administration of these various drugs, vasoconstriction usually occurred in the azygos, renal and IVC beds, since the flow through these beds decreased despite an increased perfusion pressure. Further evidence Effect of kinekard and epinephrine on perfusion pressure in an isolated gracilis muscle preparation (preparation 42) before and after the establishment of a-adrenergic blockade with phenoxybenzamine. S X 10-* ng kinekard (A) and 1 fig of epinephrine (B) added as indicated by arrows; C, 5 X 1O-* /*g kinekard added to same preparation after administration of phenoxybenzamine (15 mg/kg). in support of a direct vasoconstrictor action of kinekard, epinephrine and norepinephrine on muscle beds is provided by those experiments in which, although isolated gracilis muscles were perfused under conditions of constant flow, the introduction of these various pressor drugs was found to be associated with an increased perfusion pressure. The increased coronary blood flow may reflect active vasodilation or, alternatively, relatively slight vasoconstriction, compared with that of the renal, IVC and azygos beds, in the presence of the increased perfusion pressure.
The relative order of vasoconstriction appears to be approximately similar for all the drugs tested. This similarity may suggest common features in their mode of action. One such possible relationship would be that kinekard, like angiotensin, releases catecholamines from peripheral tissue stores. 13 That this is not a significant factor is shown by the fact that the response of the dog on heart-lung bypass to kinekard was undisturbed by the prior administration of bretylium tosylate or guanethidine, drugs known to deplete or inhibit the release of such catecholamine stores. 13 These findings are in accord with our earlier results, which indicated that the response of this preparation to kinekard was not abolished by prior reserpinization. 6 The action of kinekard on heart-lung bypass preparations and isolated gracilis muscles was completely blocked by the a-adrenergic 14 antagonist phenoxybenzamine in contrast to the partial block of angiotensin. This finding suggests that kinekard acts on the a-receptor sites 14 ' 1B in the peripheral vasculature as do epinephrine and norepinephrine, thus explaining the apparent similarities between the actions of these drugs.
The remaining possibility that kinekard acts on a centrally located tissue to release a secondary vasoconstrictor agent is not supported by its pressor action when injected into the perfusion line of the isolated gracilis muscle. From these various results it therefore may be concluded that in tiie dog kinekard acts on a-receptor sites in the peripheral circulation, an action which does not depend on or involve the release of stored catecholamines.
